Nektar Therapeutics NKTR
35.98 USD +0.07 (+0.19%)
As ofNov 18, 2026, 10:14 AM EST
35.87 Day range 36.66
33.40 52-week range 109.00
- YTD
- -14.90%
- 1 year
- -39.19%
Next earnings
Mar 11, 2027
Expected Mar 11, 2027. Consensus EPS estimate -2.46.
Included in Essentials and up
Sign in to see Estimates and results by quarter
Analyst estimates for the coming quarters next to what the company reported.
Earnings history
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 11, 2027 | Dec 30, 2026 | -2.49 | — | — | — |
| Nov 12, 2026 | Sep 30, 2026 | -2.07 | -1.63 | +0.44 | +21.26% |
| Aug 13, 2026 | Jun 30, 2026 | -1.97 | -1.23 | +0.74 | +37.56% |
| May 7, 2026 | Mar 31, 2026 | -1.58 | -1.82 | -0.24 | -15.02% |
| Mar 12, 2026 | Dec 31, 2025 | -2.47 | -1.78 | +0.69 | +28.05% |
| Nov 6, 2025 | Sep 30, 2025 | -2.85 | -1.85 | +1.00 | +35.09% |
